Compare TXMD & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXMD | NOTE |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3M | 39.9M |
| IPO Year | N/A | N/A |
| Metric | TXMD | NOTE |
|---|---|---|
| Price | $1.79 | $1.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $29.25 |
| AVG Volume (30 Days) | 125.2K | ★ 224.5K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $2,796,000.00 | ★ $102,673,000.00 |
| Revenue This Year | $427.09 | N/A |
| Revenue Next Year | N/A | $0.55 |
| P/E Ratio | $291.37 | ★ N/A |
| Revenue Growth | ★ 75.19 | N/A |
| 52 Week Low | $0.70 | $1.75 |
| 52 Week High | $2.44 | $24.36 |
| Indicator | TXMD | NOTE |
|---|---|---|
| Relative Strength Index (RSI) | 55.84 | 24.39 |
| Support Level | $1.46 | $1.88 |
| Resistance Level | $2.01 | $2.15 |
| Average True Range (ATR) | 0.18 | 0.18 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 55.17 | 0.00 |
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.